Home/Pipeline/TREHAPAN® / Ocular Lubricants

TREHAPAN® / Ocular Lubricants

Dry Eye Syndrome

CommercialActive

Key Facts

Indication

Dry Eye Syndrome

Phase

Commercial

Status

Active

Company

Visufarma

About Visufarma

Visufarma is a commercial-stage ophthalmic company formed in 2016 from the combination of Italy's Visufarma SpA and the commercial activities of France's Nicox SA. The company markets an established portfolio of products for dry eye, glaucoma, eyelid hygiene, and retinal health supplements, positioning itself as a specialized player in the European eye care market. Its strategy centers on commercializing innovative products sourced globally, supported by a focus on customer service and professional education. Visufarma is a private company with ambitions to become a recognized partner of choice in eye health across Europe and beyond.

View full company profile

Therapeutic Areas

Ophthalmology Dry Eye Disease Glaucoma Ocular Allergy Blepharitis Retinal Health

Other Dry Eye Syndrome Drugs

Drug	Company	Phase	Status
Tβ4	ReGenTree	Not Specified (Pre-clinical/Clinical)	Active
Kera Sol Tears	Surface Ophthalmics	Phase 2	Active
Voclosporin	Aurinia Pharmaceuticals	Phase 2	Status Unclear